WO1997035563A3 - Sustained-release preparation and its production - Google Patents
Sustained-release preparation and its production Download PDFInfo
- Publication number
- WO1997035563A3 WO1997035563A3 PCT/JP1997/001041 JP9701041W WO9735563A3 WO 1997035563 A3 WO1997035563 A3 WO 1997035563A3 JP 9701041 W JP9701041 W JP 9701041W WO 9735563 A3 WO9735563 A3 WO 9735563A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sustained
- production
- release preparation
- dispersing
- surfactant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU20432/97A AU2043297A (en) | 1996-03-28 | 1997-03-27 | Sustained-release preparation and its production |
AT97908520T ATE227980T1 (en) | 1996-03-28 | 1997-03-27 | SUSTAINED RELEASE PREPARATION AND PRODUCTION THEREOF |
CA002241322A CA2241322C (en) | 1996-03-28 | 1997-03-27 | Sustained-release preparation and its production |
EP97908520A EP0889722B1 (en) | 1996-03-28 | 1997-03-27 | Sustained-release preparation and its production |
US08/849,172 US6190702B1 (en) | 1996-03-28 | 1997-03-27 | Sustained-released material prepared by dispersing a lyophilized polypeptide in an oil phase |
DK97908520T DK0889722T3 (en) | 1996-03-28 | 1997-03-27 | Delayed release preparation and preparation thereof |
DE69717263T DE69717263T2 (en) | 1996-03-28 | 1997-03-27 | PREPARATION WITH DELAYED RELEASE AND THEIR PRODUCTION |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7301696 | 1996-03-28 | ||
JP8/73016 | 1996-03-28 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/849,172 A-371-Of-International US6190702B1 (en) | 1996-03-28 | 1997-03-27 | Sustained-released material prepared by dispersing a lyophilized polypeptide in an oil phase |
US09/764,052 Division US20010006678A1 (en) | 1996-03-28 | 2001-01-19 | Sustained-release material prepared by dispersing a lyophilized polypeptide in an oil phase |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1997035563A2 WO1997035563A2 (en) | 1997-10-02 |
WO1997035563A3 true WO1997035563A3 (en) | 1997-11-20 |
Family
ID=13506129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1997/001041 WO1997035563A2 (en) | 1996-03-28 | 1997-03-27 | Sustained-release preparation and its production |
Country Status (8)
Country | Link |
---|---|
US (2) | US6190702B1 (en) |
EP (1) | EP0889722B1 (en) |
AT (1) | ATE227980T1 (en) |
AU (1) | AU2043297A (en) |
CA (1) | CA2241322C (en) |
DE (1) | DE69717263T2 (en) |
DK (1) | DK0889722T3 (en) |
WO (1) | WO1997035563A2 (en) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6270795B1 (en) | 1995-11-09 | 2001-08-07 | Microbiological Research Authority | Method of making microencapsulated DNA for vaccination and gene therapy |
EP0862419B2 (en) | 1995-11-09 | 2010-11-17 | Microbiological Research Authority | Microencapsulated dna for vaccination and gene therapy |
US6287587B2 (en) | 1997-07-15 | 2001-09-11 | Takeda Chemical Industries, Ltd. | Process for producing sustained-release preparation by in-water drying |
WO1999036099A1 (en) | 1998-01-16 | 1999-07-22 | Takeda Chemical Industries, Ltd. | Sustained release compositions, process for producing the same and utilization thereof |
CA2317039C (en) * | 1998-01-21 | 2009-09-29 | Takeda Chemical Industries, Ltd. | Lyophilization method for sustained-release preparations |
WO1999048519A1 (en) | 1998-03-20 | 1999-09-30 | Takeda Chemical Industries, Ltd. | Sustained-release preparation of physiologically active polypeptide and production thereof |
GB9810236D0 (en) * | 1998-05-13 | 1998-07-08 | Microbiological Res Authority | Improvements relating to encapsulation of bioactive agents |
DE60141680D1 (en) * | 2000-01-14 | 2010-05-12 | Univ Brown Res Found | PROCESS FOR PRODUCING MICRONIZED FREEZER-DRIED PARTICLES |
US7029700B2 (en) | 2000-01-14 | 2006-04-18 | Brown University Research Foundation | Micronized freeze-dried particles |
AU4935701A (en) | 2000-03-24 | 2001-10-08 | Genentech Inc | Use of insulin for the treatment of cartilagenous disorders |
US7488761B2 (en) * | 2000-08-07 | 2009-02-10 | Orthogen Llc | Polymer containing calcium sulfate particles for bone augmentation |
US20080233165A1 (en) * | 2000-08-07 | 2008-09-25 | Biolok International, Inc. | Time release calcium sulfate and growth factor matrix for bone augmentation |
US6824822B2 (en) * | 2001-08-31 | 2004-11-30 | Alkermes Controlled Therapeutics Inc. Ii | Residual solvent extraction method and microparticles produced thereby |
EP1356809A4 (en) * | 2000-12-28 | 2008-05-14 | Takeda Pharmaceutical | Sustained release preparations |
JP2002265383A (en) * | 2001-03-14 | 2002-09-18 | Mitsubishi Pharma Corp | LIQUID PREPARATION FOR INTERFERON-alpha INJECTION |
WO2002078673A1 (en) * | 2001-03-29 | 2002-10-10 | Takeda Chemical Industries, Ltd. | Process for producing fine granulate drug |
US20040126900A1 (en) * | 2001-04-13 | 2004-07-01 | Barry Stephen E | High affinity peptide- containing nanoparticles |
US6887897B2 (en) | 2001-07-31 | 2005-05-03 | Mission Pharmacal Company | Calcium glutarate supplement and phosphorus binder |
CN1620285A (en) * | 2001-12-26 | 2005-05-25 | 武田药品工业株式会社 | Novel microsphere and method for production thereof |
EP2298806A1 (en) | 2002-10-16 | 2011-03-23 | Purdue Pharma L.P. | Antibodies that bind cell-associated CA 125/0722P and methods of use thereof |
WO2004035762A2 (en) * | 2002-10-17 | 2004-04-29 | Alkermes Controlled Therapeutics, Inc. Ii | Microencapsulation and sustained release of biologically active polypeptides |
WO2005110425A1 (en) | 2004-04-15 | 2005-11-24 | Alkermes, Inc. | Polymer-based sustained release device |
US20070219131A1 (en) * | 2004-04-15 | 2007-09-20 | Ben-Sasson Shmuel A | Compositions capable of facilitating penetration across a biological barrier |
US7456254B2 (en) * | 2004-04-15 | 2008-11-25 | Alkermes, Inc. | Polymer-based sustained release device |
US20060110423A1 (en) * | 2004-04-15 | 2006-05-25 | Wright Steven G | Polymer-based sustained release device |
US8075910B2 (en) * | 2004-05-20 | 2011-12-13 | Pbm Pharmaceuticals, Inc. | Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
ES2338039T3 (en) * | 2005-04-13 | 2010-05-03 | ABBOTT GMBH & CO. KG | PROCEDURE FOR THE CAREFUL OBTAINING OF SUPPLIES OF ELEVATE FINE PARTICLES AND ELEVATE FINE PARTICLES, AS WELL AS THE APPLICATION. |
DE102005017777A1 (en) * | 2005-04-13 | 2006-10-19 | Pharmasol Gmbh | Preparation of high fine particle suspension comprises dissolving solid in a solvent, freezing, lyophilizing solid matrix, withdrawing solid matrix from solvent and dispersing in an external phase and applying high power on the dispersion |
PL2359808T3 (en) | 2006-08-09 | 2013-10-31 | Intarcia Therapeutics Inc | Osmotic delivery systems and piston assemblies |
EP2131815A4 (en) * | 2007-03-22 | 2012-11-07 | Alkermes Inc | Coacervation process |
MX2009011123A (en) | 2007-04-23 | 2009-11-02 | Intarcia Therapeutics Inc | Suspension formulations of insulinotropic peptides and uses thereof. |
US20080317865A1 (en) * | 2007-06-20 | 2008-12-25 | Alkermes, Inc. | Quench liquids and washing systems for production of microparticles |
EP2044934A1 (en) | 2007-10-01 | 2009-04-08 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Dispersion of poloxamer-protein particles, methods of manufacturing and uses thereof |
EP2240155B1 (en) | 2008-02-13 | 2012-06-06 | Intarcia Therapeutics, Inc | Devices, formulations, and methods for delivery of multiple beneficial agents |
LT2341905T (en) * | 2008-09-04 | 2020-09-25 | Amylin Pharmaceuticals, Llc | Sustained release formulations using non-aqueous carriers |
BRPI0918652B1 (en) | 2008-09-17 | 2021-10-19 | Chiasma, Inc. | PHARMACEUTICAL COMPOSITION INCLUDING A HYDROPHOBIC MEDIUM AND A SOLID FORM WHICH INCLUDES POLYPEPTIDE AND MEDIUM CHAIN FATTY ACID SALT, PRODUCTION PROCESS AND ORAL DOSAGE FORM |
NZ598686A (en) | 2009-09-28 | 2014-05-30 | Intarcia Therapeutics Inc | Rapid establishment and/or termination of substantial steady-state drug delivery |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
EP3253401A4 (en) | 2015-02-03 | 2018-11-21 | Chiasma Inc. | Method of treating diseases |
AU2016270984B2 (en) | 2015-06-03 | 2021-02-25 | Intarcia Therapeutics, Inc. | Implant placement and removal systems |
CN109310743A (en) | 2016-05-16 | 2019-02-05 | 因塔西亚制药公司 | Glucagon receptor selectivity polypeptide and its application method |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
EP3565580B1 (en) | 2017-01-03 | 2024-03-06 | i2o Therapeutics, Inc. | Continuous administration of exenatide and co-adminstration of acetaminophen, ethinylestradiol or levonorgestrel |
EP4218738A1 (en) | 2017-02-24 | 2023-08-02 | The Regents of The University of California | Particle-drop structures and methods for making and using the same |
US11141457B1 (en) | 2020-12-28 | 2021-10-12 | Amryt Endo, Inc. | Oral octreotide therapy and contraceptive methods |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4963367A (en) * | 1984-04-27 | 1990-10-16 | Medaphore, Inc. | Drug delivery compositions and methods |
US5288502A (en) * | 1991-10-16 | 1994-02-22 | The University Of Texas System | Preparation and uses of multi-phase microspheres |
EP0633020A1 (en) * | 1993-07-05 | 1995-01-11 | Takeda Chemical Industries, Ltd. | Method of producing sustained-release preparation |
WO1995011009A1 (en) * | 1993-10-22 | 1995-04-27 | Genentech, Inc. | Method for preparing microspheres comprising a fluidized bed drying step |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5385738A (en) | 1983-10-14 | 1995-01-31 | Sumitomo Pharmaceuticals Company, Ltd. | Sustained-release injection |
US4774091A (en) | 1983-10-14 | 1988-09-27 | Sumitomo Pharmaceuticals Company, Ltd. | Long-term sustained-release preparation |
US4962091A (en) | 1986-05-23 | 1990-10-09 | Syntex (U.S.A.) Inc. | Controlled release of macromolecular polypeptides |
JP3116311B2 (en) | 1990-06-13 | 2000-12-11 | エーザイ株式会社 | Manufacturing method of microsphere |
NO302481B1 (en) * | 1990-10-16 | 1998-03-09 | Takeda Chemical Industries Ltd | Polymer for an extended release preparation, as well as an extended release preparation |
ATE195652T1 (en) | 1992-12-02 | 2000-09-15 | Alkermes Inc | CONTROLLED RELEASE MICROSPHERES CONTAINING GROWTH HORMONE |
ATE197550T1 (en) | 1993-02-23 | 2000-12-15 | Genentech Inc | STABILIZATION OF POLYPEPTIDES TREATED WITH ORGANIC SOLVENTS USING AN EXCIPIENT |
US6117455A (en) * | 1994-09-30 | 2000-09-12 | Takeda Chemical Industries, Ltd. | Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent |
TW448055B (en) * | 1995-09-04 | 2001-08-01 | Takeda Chemical Industries Ltd | Method of production of sustained-release preparation |
EP0765660A3 (en) * | 1995-09-28 | 1998-09-23 | Takeda Chemical Industries, Ltd. | Microcapsules comprising 2-piperazinone-1-acetic acid compounds |
-
1997
- 1997-03-27 EP EP97908520A patent/EP0889722B1/en not_active Expired - Lifetime
- 1997-03-27 AT AT97908520T patent/ATE227980T1/en not_active IP Right Cessation
- 1997-03-27 DE DE69717263T patent/DE69717263T2/en not_active Expired - Lifetime
- 1997-03-27 DK DK97908520T patent/DK0889722T3/en active
- 1997-03-27 CA CA002241322A patent/CA2241322C/en not_active Expired - Fee Related
- 1997-03-27 US US08/849,172 patent/US6190702B1/en not_active Expired - Lifetime
- 1997-03-27 AU AU20432/97A patent/AU2043297A/en not_active Abandoned
- 1997-03-27 WO PCT/JP1997/001041 patent/WO1997035563A2/en active IP Right Grant
-
2001
- 2001-01-19 US US09/764,052 patent/US20010006678A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4963367A (en) * | 1984-04-27 | 1990-10-16 | Medaphore, Inc. | Drug delivery compositions and methods |
US5288502A (en) * | 1991-10-16 | 1994-02-22 | The University Of Texas System | Preparation and uses of multi-phase microspheres |
EP0633020A1 (en) * | 1993-07-05 | 1995-01-11 | Takeda Chemical Industries, Ltd. | Method of producing sustained-release preparation |
WO1995011009A1 (en) * | 1993-10-22 | 1995-04-27 | Genentech, Inc. | Method for preparing microspheres comprising a fluidized bed drying step |
Also Published As
Publication number | Publication date |
---|---|
US6190702B1 (en) | 2001-02-20 |
EP0889722A2 (en) | 1999-01-13 |
US20010006678A1 (en) | 2001-07-05 |
AU2043297A (en) | 1997-10-17 |
CA2241322A1 (en) | 1997-10-02 |
DK0889722T3 (en) | 2003-02-10 |
DE69717263T2 (en) | 2003-07-24 |
DE69717263D1 (en) | 2003-01-02 |
EP0889722B1 (en) | 2002-11-20 |
CA2241322C (en) | 2009-01-13 |
WO1997035563A2 (en) | 1997-10-02 |
ATE227980T1 (en) | 2002-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1997035563A3 (en) | Sustained-release preparation and its production | |
AU6242096A (en) | Method of producing sustained-release preparation | |
AU4843396A (en) | Processed fish meat, fish meat material prepared by using the same, and process for producing processed fish meat | |
AU2860795A (en) | Process for forming improved ripled chip-type products | |
AU2503788A (en) | Process for the production of biodegradable microcapsules of water-soluble peptides and proteins, and microcapsules obtained by this process | |
AU5678396A (en) | Methods of preparing soluble, oligomeric proteins | |
CA2141555A1 (en) | Morphogenic protein soluble complex and composition thereof | |
MX9605272A (en) | Process to prepare nicotinamide. | |
AU6137496A (en) | Process for producing guanidine derivatives, intermediates therefor and their production | |
AU7283396A (en) | Process for producing solid vitamin preparations | |
AU1920197A (en) | Method of producing objects by folding flat material and object produced according to this method | |
AU5579494A (en) | Method of producing collagen-containing semi-finished product | |
AU4201393A (en) | Starch intermediate product, process for producing it and process for its further processing | |
AU6863494A (en) | Method for producing vegetable pasta | |
AU626700B2 (en) | Process for the production of hydrolyzed vegetable proteins and the product therefrom | |
CA2025678A1 (en) | Natural delta-lactones and process of the production thereof | |
CA2157387A1 (en) | Method and compositions for recombinant osteogenic protein production | |
AU3369289A (en) | Process for producing shaped food | |
AU2278592A (en) | Method for continuously producing partially hydrolyzed starch, product thereby obtained and uses thereof | |
AU4304496A (en) | Method of producing shaped articles | |
EP0297743A3 (en) | Texturising process and apparatus | |
GB9515018D0 (en) | Process for producing an instant pasta product | |
CA2098277A1 (en) | Preparation of formyltetrahydropyrans | |
AUPN658795A0 (en) | Method of producing alpha 2, 3 sialyltransferase | |
AU693483B2 (en) | Base for sustained-release preparation, sustained-release preparation, and process for producing the preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 08849172 Country of ref document: US |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AU AZ BA BB BG BR BY CA CN CU CZ EE GE GH HU IL IS KG KR KZ LC LK LR LT LV MD MG MK MN MX NO NZ PL RO RU SG SI SK TJ TM TR TT UA US UZ VN YU AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AU AZ BA BB BG BR BY CA CN CU CZ EE GE GH HU IL IS KG KR KZ LC LK LR LT LV MD MG MK MN MX NO NZ PL RO RU SG SI SK TJ TM TR TT UA US UZ VN YU AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1997908520 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2241322 Country of ref document: CA Ref country code: CA Ref document number: 2241322 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 1997908520 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1997908520 Country of ref document: EP |